Careers  |  Sign In  |  Register  |   Twitter

Latest in Oncology

A new report in the British Medical Journal examined the long term effects of indoor tanning on the risk of non-melanoma skin cancer. 9,328 patients with non-melanoma skin cancer were surveyed, and "among people who reported ever using indoor tanning compared with those who never used indoor tanning, the...
In an effort to improve progression-free survival, response rate, and time to symptom progression in breast cancer treatment, a new study in The New England Journal of Medicine investigated the efficacy of a new drug, Trastuzumab emtansine (T-DM1). It is "an antibody–drug conjugate incorporating the...
New research published in The New England Journal of Medicine shows that combined treatment with dabrafenib, a selective BRAF inhibitor, and trametinib, a selective MAPK kinase (MEK) inhibitor, may be a better treatment for metastatic melanoma with BRAF V600 mutations than dabrafenib monotherapy. A...